e-learning
resources
Vienna 2012
Monday, 03.09.2012
Hot topics in respiratory infections
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Pulmonary immunostimulation with macrophage-activating lipopeptide-2 in influenza-A-virus infected mice increased survival of subsequent pneumococcal pneumonia
K. Reppe, P. Radünzel, T. Tschernig, T. Wolff, A. Gruber, N. Suttorp, M. Witzenrath (Berlin, Homburg/Saar, Germany)
Source:
Annual Congress 2012 - Hot topics in respiratory infections
Session:
Hot topics in respiratory infections
Session type:
Oral Presentation
Number:
2816
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
K. Reppe, P. Radünzel, T. Tschernig, T. Wolff, A. Gruber, N. Suttorp, M. Witzenrath (Berlin, Homburg/Saar, Germany). Pulmonary immunostimulation with macrophage-activating lipopeptide-2 in influenza-A-virus infected mice increased survival of subsequent pneumococcal pneumonia. Eur Respir J 2012; 40: Suppl. 56, 2816
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Middle-long term pulmonary abnormalities after severe COVID-19 pneumonia which required invasive ventilation
Related content which might interest you:
Pulmonary fibrosis in mice increases susceptibility to pneumococcal pneumonia and bacteremia
Source: Virtual Congress 2021 – Environmental and lifestyle impacts on chronic lung disease
Year: 2021
Impact of nasopharyngeal pneumococcal colonization on dendritic cell-dependent protective immunity against invasive pneumococcal disease in mice
Source: International Congress 2016 – Community-acquired pneumonia: risk classes and management issues
Year: 2016
Intranasal administration of lipopolysaccharide (LPS) during a chronic pulmonary infection with
streptococcus pneumoniae
resulted in a synergistic effect on neutrophil influx in mice
Source: International Congress 2014 – Cells, biofilms and biomarkers in respiratory infections
Year: 2014
Influence of the infecting serotype on the development of complications in bacteriemic pneumococcal pneumonia with high inflammatory response
Source: Virtual Congress 2020 – Lower respiratory tract infections in clinical practice
Year: 2020
The impact of time on the systemic inflammatory response in pneumococcal pneumonia
Source: Eur Respir J 2010; 35: 614-618
Year: 2010
Heterologous infection causes pneumonia and impairs alveolar macrophage function in mice
Source: Annual Congress 2008 - Mechanisms of respiratory infections: interaction between the pathogen and the host
Year: 2008
A novel TNF inhibitor does not compromise host immunity to mycobacterium tuberculosis and BCG infections and still protects from hepatitis
Source: Annual Congress 2009 - Clinical immunology of tuberculosis
Year: 2009
Emergence of an immunosuppressive neutrophil phenotype during pneumococcal lung co-infection with influenza A virus
Source: International Congress 2019 – Host-microbe interactions in lung disease and exacerbations
Year: 2019
Pulmonary infection
with
Mycobacterium avium
in immunocompetent children without IFN-γ
(interferon-gamma)
or IL-12-receptor deficiency
Source: Eur Respir J 2001; 18: Suppl. 33, 511s
Year: 2001
Viral infection of macrophages reduces CD36 expression: Implications for phagocytosis of non-typeable haemophilus influenzae
Source: International Congress 2015 – Viral infections: basic research and clinical perspective
Year: 2015
Macrophage activation in exacerbated COPD with and without community-acquired pneumonia
Source: Eur Respir J 2010; 36: 285
Year: 2010
Protective efficacy and antigenicity of influenza HA-VLPs in a murine model of postinfluenza bacterial pneumonia.
Source: International Congress 2019 – Clinical challenges in respiratory infection
Year: 2019
Impact of nasopharyngeal pneumococcal colonization on protective immunity against S. pneumoniae in mice
Source: International Congress 2015 – Advances from translational research in respiratory infections
Year: 2015
Therapeutic effect of adenoviral vector-mediated GM-CSF gene transfer in lung antimycobacterial immunity in M. bovis BCG infected mice
Source: International Congress 2016 – Rifampicin resistance, MDRTB, and new drug treatments
Year: 2016
Downregulation of RTI
40
/T1α protein in pneumococcal pneumonia
Source: Eur Respir J 2004; 24: Suppl. 48, 719s
Year: 2004
PcrV antibody prophylaxis in combination with antibiotic therapy reduces lung injury and improves survival in pseudomonas aeruginosa infected mice
Source: Annual Congress 2011 - Antimicrobial treatment and resistance in lower respiratory tract infections
Year: 2011
The effect of clarithromycin on immunity of mice with chronic respiratory infection caused by
P. aeruginosa
Source: Annual Congress 2008 - Aetiology of respiratory infections: mycobacteria and fungi
Year: 2008
MAIT cells protect against fatal intracellular pulmonary legionella infection via IFN-?
Source: International Congress 2017 – From microbiology to clinical work
Year: 2017
Factors associated with inflammatory cytokine patterns in community-acquired pneumonia
Source: Eur Respir J 2011; 37: 393
Year: 2011
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept